Iso certified drug testing manufacturer hand sanitizer, drug test, mask, bleach, saliva drug test, alcohol test, alcohol hand sanitizers, ppe supplies, mask, face shields, hand sanitizer, nebulizers, drug test cups, point of care rapid test kits, oral , urine and blood. rapid covid test kits antibody and antigen..
CLIA Waived Use of this test with all authorized specimen types is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests. This test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. The CLIA Waived COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Emergency use of this test is limited to authorized laboratories. About Test Device EUA Authorized CE Mark Test does NOT give positive or negative result for COVID-19 virus. This is an antibody test, it only indicates past or recent infection. Read Results in 15 Minutes 9 Month Expiration from Date of Manufacture Contents 20 Test Devices 20 Disposable Pipettes 20 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within the first five days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Lateral flow assay Detect SARS-CoV-2 nucleocapsid protein antigen Rapid results within 10-15 minutes Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation For use under the Emergency Use Authorization (EUA) only For in vitro diagnostic use only For prescription use only For use with direct anterior nasal and nasopharyngeal swab specimens Clinical Performance 93.75% PPAa and 99.32% NPAb when used with nasopharyngeal swab 87.18% PPAa and 100% NPAb when used with anterior nasal swab
Q.E.D. Saliva Alcohol Testing The Q.E.D. Saliva Alcohol Test is the on-the-spot leader in the rapid, accurate and quantitative determination of alcohol in saliva. With a high correlation to blood-alcohol levels, Q.E.D. has a testing range of 0-145 mg/dL and provides quantitative results in minutes. It's Reliable, Fast, Simple... Non-invasive Quantitative results in minutes Reads like a thermometer No instrumentation Long shelf life Built-in QA Spot assures quality control for every test
Master Carton - Contains 625 Tests For International Sale Only - Call for Pricing The COVID-19 IgG/IgM Rapid Test Device is an in vitro Immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. About Test Device Gives Positive or Negative Result for COVID-19 IgM/IgG antibodies Read Results in 15 Minutes Contents of each box 25 Test Devices 25 Disposable Pipettes 25 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
Complete rapid testing & ppe solutions. multi panel drug test cups, cards, cassettes, saliva drug tests, alcohol tests, pregnancy tests, covid tests, infectious disease tests, & cardiac test. ppe include earloop masks, sanitizers, n95 nisoh masks, nitrile exam, nitrile blend, vinyl exam and food grade gloves, wipes, face shields.
INTENDED USE UrineCheck 7 is a fast dip-and-read test for the determination of diluted or adulterated urine specimens. It is an important pre-screening test for any drug-testing program. Each bottle contains 25 strips. SUMMARY AND EXPLANATION UrineCheck 7 drug adulteration tests are firm plastic strips to which seven different reagent areas are affixed. UrineCheck 7 test strips are ready-to-use and disposable. No equipment is required for its use. Only fresh and uncentrifuged urine samples without preservatives are to be used. UrineCheck 7 provides tests for Creatinine, Nitrite, pH, Specific Gravity, Glutaraldehyde, Oxidants, and Pyridium Chlorochromate in urine. Test results may be useful for assessing the integrity of the urine sample prior to Drugs-of-Abuse testing; for example, whether the sample is possibly diluted with water or other liquids as indicated by the creatinine and specific gravity tests. UrineCheck 7 detects whether the sample contains commercially available adulterants including nitrite, glutaraldehyde, bleach, pyridinium chlorochromate and other oxidizing agents. UrineCheck 7 can also assess whether the sample is possibly contaminated by acidic (vinegar) or basic (ammonia solution) adulterants as indicated by the pH test.
Apple APP iOS Android 4.3 with Bluetooth4.0 European Fuel cell sensor Bluetooth for wireless Replaceable mouthpiece 1 pcs AAA battery (500 tests) Size: 80x50x18mm Display: 0.00-4.00 (2.00mg/L) Accuracy: +/- 0.05 at 0.50 (APP on Smartphone) Alcohol limit/unit selectable Recall tested memory SMS/Facebook/Twitter to share Zero/Safety alcohol estimation
The Mission Breath Alcohol Detector is intended to measure alcohol in human breath. Results are used in the diagnosis of alcohol intoxication. The Mission Breath Alcohol Detector is a semi-qualitative rapid screening test. It indicates relative Blood Alcohol Concentration (BAC) at 0.02% cutoff level. Each detector contains crystals that detect a specific cutoff level of BAC. Alcohol reacts with the crystals in the detector to produce a color change. If the test is positive, the amount of alcohol in the breath is greater than or equal to the cutoff level of the detector. 3-year shelf-life at room temperature Results in 2 minutes Easy to perform and interpret
BreathScan is a fast, easy and portable way to help detect the presence of alcohol on someone's breath. Given the negative affect that alcohol can have on the public's health and safety, alcohol screening tests, like BreathSca can help prevent individuals who use alcohol improperly from creating undo harm to themselves and others. BreathScan Detectors are available in the following Breath Alcohol Levels: .02%, .04%, .05% and .08%. BENEFITS: 4 steps to complete, 2 minutes to obtain results Single-Use, disposable device that's small enough to fit in your pocket Easy To Use & Fast Results FDA 501(k) Cleared and CLIA Waived Alcohol is America's #1 drug Over 65% of all substance abuse is related to alcohol Alcohol is involved in at least 50% of all highway fatalities Every 33 minutes an American dies in an alcohol-related crash 30% of all hospital admissions are alcohol-related 65% of kids who start drinking by age 15 will end up trying illegal drugs. BreathScan Single Use Breath Alcohol Test-Detection Level - .05%
BreathScan is a fast, easy and portable way to help detect the presence of alcohol on someone's breath. Given the negative affect that alcohol can have on the public's health and safety, alcohol screening tests, like BreathScan can help prevent individuals who use alcohol improperly from creating undo harm to themselves and others. BreathScan Detectors are available in the following Breath Alcohol Levels: .02%, .04%, .05% and .08%. BENEFITS: 4 steps to complete, 2 minutes to obtain results Single-Use, disposable device that's small enough to fit in your pocket Easy To Use & Fast Results FDA 501(k) Cleared and CLIA Waived Alcohol is America's #1 drug Over 65% of all substance abuse is related to alcohol Alcohol is involved in at least 50% of all highway fatalities Every 33 minutes an American dies in an alcohol-related crash 30% of all hospital admissions are alcohol-related 65% of kids who start drinking by age 15 will end up trying illegal drugs.
Q.E.D. Saliva Alcohol Testing The Q.E.D. Saliva Alcohol Test is the on-the-spot leader in the rapid, accurate and quantitative determination of alcohol in saliva. With a high correlation to blood-alcohol levels, Q.E.D. has a testing range of 0-145 mg/dL and provides quantitative results in minutes. Its Reliable, Fast, Simple... Non-invasive Quantitative results in minutes Reads like a thermometer No instrumentation Long shelf life Built-in QA Spot assures quality control for every test
The Mission Breath Alcohol Detector is intended to measure alcohol in human breath. Results are used in the diagnosis of alcohol intoxication. The Mission Breath Alcohol Detector is a semi-qualitative rapid screening test. It indicates relative Blood Alcohol Concentration (BAC) at 0.02% cutoff level. Each detector contains crystals that detect a specific cutoff level of BAC. Alcohol reacts with the crystals in the detector to produce a color change. If the test is positive, the amount of alcohol in the breath is greater than or equal to the cutoff level of the detector. 3-year shelf-life at room temperature Results in 2 minutes Easy to perform and interpret
BreathScan is a fast, easy and portable way to help detect the presence of alcohol on someone's breath. Given the negative affect that alcohol can have on the public's health and safety, alcohol screening tests, like BreathScan, can help prevent individuals who use alcohol improperly from creating undo harm to themselves and others. BreathScan Detectors are available in the following Breath Alcohol Levels: .02%, .04%, .05% and .08%. BENEFITS: 4 steps to complete, 2 minutes to obtain results Single-Use, disposable device that's small enough to fit in your pocket Easy To Use & Fast Results FDA 501(k) Cleared and CLIA Waived Alcohol is America's #1 drug Over 65% of all substance abuse is related to alcohol Alcohol is involved in at least 50% of all highway fatalities Every 33 minutes an American dies in an alcohol-related crash 30% of all hospital admissions are alcohol-related 65% of kids who start drinking by age 15 will end up trying illegal drugs. BreathScan Single Use Breath Alcohol Test-Detection Level - .08%
BreathScan is a fast, easy and portable way to help detect the presence of alcohol on someone's breath. Given the negative affect that alcohol can have on the public's health and safety, alcohol screening tests, like BreathScan, can help prevent individuals who use alcohol improperly from creating undo harm to themselves and others. BreathScan Detectors are available in the following Breath Alcohol Levels: .02%, .04%, .05% and .08%. BENEFITS: 4 steps to complete, 2 minutes to obtain results Single-Use, disposable device that's small enough to fit in your pocket Easy To Use & Fast Results FDA 501(k) Cleared and CLIA Waived Alcohol is America's #1 drug Over 65% of all substance abuse is related to alcohol Alcohol is involved in at least 50% of all highway fatalities Every 33 minutes an American dies in an alcohol-related crash 30% of all hospital admissions are alcohol-related 65% of kids who start drinking by age 15 will end up trying illegal drugs. BreathScan Single Use Breath Alcohol Test-Detection Level - .02%
The Precision DX - ETG Test strip is a fast visual, competitive panel immunoassay that can be used for the detection of ETG drug metabolites at specific cutoff levels in human urine. Read results at 5 minutes 500 ng/mL cut-off Compared to Lab Tests Compared to Generic, it's easier to interpret, more accurate, and reads faster Results remain valid for up to 4 hours after test initiation These are screening devices read positive or negative, qualitative, and although highly accurate, if you read a positive we recommend a certified lab for LC-MS/MS Confirmation. For more information dial 1-866-526-2873 or email sales@americanscreeningcorp.com. These drug tests are intended for workplace testing & forensic use ONLY (not FDA cleared or CLIA waived).
DESCRIPTION: Apple APP iOS Android 4.3 with Bluetooth4.0 European Fuel cell sensor Bluetooth for wireless Replaceable mouthpiece 1 pcs AAA battery (500 tests) Size: 80x50x18mm Display: 0.00-4.00â?° (2.00mg/L) Accuracy: +/- 0.05â?° at 0.50â?° (APP on Smartphone) Alcohol limit/unit selectable Recall tested memory
BreathScan is a fast, easy and portable way to help detect the presence of alcohol on someone's breath. Given the negative affect that alcohol can have on the public's health and safety, alcohol screening tests, like BreathScan, can help prevent individuals who use alcohol improperly from creating undo harm to themselves and others. BreathScan Detectors are available in the following Breath Alcohol Levels: .02%, .04%, .05% and .08%. BENEFITS: 4 steps to complete, 2 minutes to obtain results Single-Use, disposable device that's small enough to fit in your pocket Easy To Use & Fast Results FDA 501(k) Cleared and CLIA Waived Alcohol is America's #1 drug Over 65% of all substance abuse is related to alcohol Alcohol is involved in at least 50% of all highway fatalities Every 33 minutes an American dies in an alcohol-related crash 30% of all hospital admissions are alcohol-related 65% of kids who start drinking by age 15 will end up trying illegal drugs. BreathScan Single Use Breath Alcohol Test-Detection Level - .02%
The CLIA Waived COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Emergency use of this test is limited to authorized laboratories. About Test Device EUA Authorized CE Mark Gives Positive or Negative Result for COVID-19 virus Read Results in 15 Minutes 24 Month Expiration from Date of Manufacture Contents 20 Test Devices 20 Disposable Pipettes 20 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
CLIA Waived Use of this test with all authorized specimen types is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests. This test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. The COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. About Test Device EUA Authorized Gives Positive or Negative Result for COVID-19 virus Read Results in 15 Minutes 24 Month Expiration from Date of Manufacture Contents 20 Test Devices 20 Disposable Pipettes 20 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
